Lonza Group Ltd (LZAGF)
537.04
-22.96
(-4.10%)
USD |
OTCM |
May 01, 16:00
Lonza Group Price to Book Value: 3.442 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 3.442 |
| April 30, 2024 | 3.589 |
| April 29, 2024 | 3.685 |
| April 26, 2024 | 3.549 |
| April 25, 2024 | 3.499 |
| April 24, 2024 | 3.574 |
| April 23, 2024 | 3.581 |
| April 22, 2024 | 3.468 |
| April 19, 2024 | 3.512 |
| April 18, 2024 | 3.611 |
| April 17, 2024 | 3.711 |
| April 16, 2024 | 3.669 |
| April 15, 2024 | 3.702 |
| April 12, 2024 | 3.762 |
| April 11, 2024 | 3.783 |
| April 10, 2024 | 3.726 |
| April 09, 2024 | 3.866 |
| April 08, 2024 | 3.861 |
| April 05, 2024 | 3.864 |
| April 04, 2024 | 3.884 |
| April 03, 2024 | 3.932 |
| April 02, 2024 | 3.752 |
| April 01, 2024 | 3.845 |
| March 28, 2024 | 3.855 |
| March 27, 2024 | 3.826 |
| Date | Value |
|---|---|
| March 26, 2024 | 3.794 |
| March 25, 2024 | 3.754 |
| March 22, 2024 | 3.743 |
| March 21, 2024 | 3.774 |
| March 20, 2024 | 3.807 |
| March 19, 2024 | 3.483 |
| March 18, 2024 | 3.473 |
| March 15, 2024 | 3.537 |
| March 14, 2024 | 3.482 |
| March 13, 2024 | 3.456 |
| March 12, 2024 | 3.320 |
| March 11, 2024 | 3.367 |
| March 08, 2024 | 3.389 |
| March 07, 2024 | 3.422 |
| March 06, 2024 | 3.320 |
| March 05, 2024 | 3.307 |
| March 04, 2024 | 3.326 |
| March 01, 2024 | 3.400 |
| February 29, 2024 | 3.339 |
| February 28, 2024 | 3.396 |
| February 27, 2024 | 3.396 |
| February 26, 2024 | 3.328 |
| February 23, 2024 | 3.413 |
| February 22, 2024 | 3.377 |
| February 21, 2024 | 3.300 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.178
Minimum
Oct 30 2023
8.023
Maximum
Sep 02 2021
4.787
Average
4.172
Median
Aug 20 2019
Price to Book Value Benchmarks
| Roche Holding AG | 5.437 |
| AC Immune SA | 1.288 |
| CRISPR Therapeutics AG | 2.425 |
| Addex Therapeutics Ltd | 6.356 |
Price to Book Value Related Metrics
| PE Ratio | 54.07 |
| PS Ratio | 5.255 |
| Price | 537.04 |
| Earnings Yield | 1.85% |
| Market Cap | 38.73B |
| Operating PE Ratio | 40.57 |
| Normalized PE Ratio | 53.86 |